DrugPatentWatch Database Preview
Betaxolol hydrochloride - Generic Drug Details
» See Plans and Pricing
What are the generic sources for betaxolol hydrochloride and what is the scope of freedom to operate?
Betaxolol hydrochloride
is the generic ingredient in six branded drugs marketed by Akorn, Apotex Inc, Medimetriks Pharms, Wockhardt, Sandoz Inc, Novartis, Epic Pharma, Kvk Tech, Sanofi Aventis Us, and Alcon, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for betaxolol hydrochloride. Seven suppliers are listed for this compound.
Summary for betaxolol hydrochloride
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 10 |
NDAs: | 11 |
Drug Master File Entries: | 11 |
Suppliers / Packagers: | 7 |
Bulk Api Vendors: | 88 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | betaxolol hydrochloride at DailyMed |
Recent Clinical Trials for betaxolol hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University | Phase 1 |
University of Oklahoma | Phase 1 |
The University of Texas Health Science Center, Houston | Phase 1 |
Pharmacology for betaxolol hydrochloride
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for betaxolol hydrochloride
Paragraph IV (Patent) Challenges for BETAXOLOL HYDROCHLORIDE
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
BETOPTIC | SOLUTION/DROPS;OPHTHALMIC | betaxolol hydrochloride | 019270 |
US Patents and Regulatory Information for betaxolol hydrochloride
Expired US Patents for betaxolol hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | BETOPTIC S | betaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 019845-001 | Dec 29, 1989 | Start Trial | Start Trial |
Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | Start Trial | Start Trial |
Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | Start Trial | Start Trial |
Novartis | BETOPTIC S | betaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 019845-001 | Dec 29, 1989 | Start Trial | Start Trial |
Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.